These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 20371338)

  • 1. It's diagnostics, stupid.
    Bernards R
    Cell; 2010 Apr; 141(1):13-7. PubMed ID: 20371338
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Response predictive biomarkers to targeted therapies in oncology].
    Harlé A; Merlin JL
    Ann Biol Clin (Paris); 2013 Nov; 71():89-97. PubMed ID: 24235332
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Advances and challenges in the use of biomarkers in clinical trials.
    Chabner B
    Clin Adv Hematol Oncol; 2008 Jan; 6(1):42-3. PubMed ID: 18322440
    [No Abstract]   [Full Text] [Related]  

  • 4. The role of molecular imaging in drug discovery and development.
    Hargreaves RJ
    Clin Pharmacol Ther; 2008 Feb; 83(2):349-53. PubMed ID: 18167503
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The epothilones: translating from the laboratory to the clinic.
    Lee JJ; Swain SM
    Clin Cancer Res; 2008 Mar; 14(6):1618-24. PubMed ID: 18347162
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The burden of scientific progress: growing inequalities in the delivery of cancer care.
    Mano M
    Acta Oncol; 2006; 45(1):84-6. PubMed ID: 16464800
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Advances in biomarkers for targeted agents.
    Maitland ML
    Clin Adv Hematol Oncol; 2011 Sep; 9(9):688-90. PubMed ID: 22402514
    [No Abstract]   [Full Text] [Related]  

  • 8. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H; Namba K
    Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recent advances in biomarkers for cancer diagnosis and treatment.
    Manne U; Srivastava RG; Srivastava S
    Drug Discov Today; 2005 Jul; 10(14):965-76. PubMed ID: 16023055
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A prototypical process for creating evidentiary standards for biomarkers and diagnostics.
    Altar CA; Amakye D; Bounos D; Bloom J; Clack G; Dean R; Devanarayan V; Fu D; Furlong S; Hinman L; Girman C; Lathia C; Lesko L; Madani S; Mayne J; Meyer J; Raunig D; Sager P; Williams SA; Wong P; Zerba K
    Clin Pharmacol Ther; 2008 Feb; 83(2):368-71. PubMed ID: 18091762
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Biomarkers Consortium: on the critical path of drug discovery.
    Altar CA
    Clin Pharmacol Ther; 2008 Feb; 83(2):361-4. PubMed ID: 18183037
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Systems biology makes it personal.
    Brynildsen MP; Collins JJ
    Mol Cell; 2009 Apr; 34(2):137-8. PubMed ID: 19394290
    [TBL] [Abstract][Full Text] [Related]  

  • 13. What if it's cancer?
    Susman J
    J Fam Pract; 2008 Feb; 57(2):75. PubMed ID: 18248725
    [No Abstract]   [Full Text] [Related]  

  • 14. Biomarkers in drug development: friend or foe? A personal reflection gained working within oncology.
    Carroll KJ
    Pharm Stat; 2007; 6(4):253-60. PubMed ID: 17351904
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The opportunities and challenges of personalized genome-based molecular therapies for cancer: targets, technologies, and molecular chaperones.
    Workman P
    Cancer Chemother Pharmacol; 2003 Jul; 52 Suppl 1():S45-56. PubMed ID: 12819933
    [TBL] [Abstract][Full Text] [Related]  

  • 16. American Society of Clinical Oncology guidance statement: the cost of cancer care.
    Meropol NJ; Schrag D; Smith TJ; Mulvey TM; Langdon RM; Blum D; Ubel PA; Schnipper LE;
    J Clin Oncol; 2009 Aug; 27(23):3868-74. PubMed ID: 19581533
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A rationale for conducting parallel mechanistic studies in clinical trials of pharmacotherapy.
    Becker RC
    J Thromb Thrombolysis; 2008 Jun; 25(3):300-2. PubMed ID: 18470653
    [No Abstract]   [Full Text] [Related]  

  • 18. Response to comment on: 'evaluation of chemoresponse assays as predictive biomarkers'.
    Korn EL; Freidlin B
    Br J Cancer; 2015 Jun; 112(12):1978. PubMed ID: 25965166
    [No Abstract]   [Full Text] [Related]  

  • 19. Loss-of-function genetic screens as a tool to improve the diagnosis and treatment of cancer.
    Mullenders J; Bernards R
    Oncogene; 2009 Dec; 28(50):4409-20. PubMed ID: 19767776
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epidermal growth factor receptor inhibitors in cancer treatment: advances, challenges and opportunities.
    Modjtahedi H; Essapen S
    Anticancer Drugs; 2009 Nov; 20(10):851-5. PubMed ID: 19826350
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.